| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Revenue | $12.7M | -4.0% |
| Cost of Revenue | $8.0M | -9.2% |
| Gross Profit | $4.7M | +6.0% |
| R&D Expense | $1.9M | +803.9% |
| SG&A Expense | $7.6M | -14.3% |
| Operating Income | -$4.7M | -2.9% |
| Pre-tax Income | -$5.0M | +3.0% |
| Income Tax | -$196K | -493.9% |
| Net Income | -$4.8M |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.1M | -18.1% |
| Accounts Receivable | $2.9M | +12.7% |
| Inventory | $2.7M | -4.9% |
| Current Assets | $12.5M | -9.1% |
| Total Assets | $14.7M | -9.2% |
| Current Liabilities | $3.7M | +0.1% |
| Total Liabilities | $8.6M | +4.2% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.4M | +61.0% |
| Capital Expenditures | $17K | -93.7% |
| Investing Cash Flow | -$2K | +99.2% |
| Financing Cash Flow | $1.7M | -32.7% |
| Free Cash Flow | -$2.4M | +62.4% |
| +6.1% |
| EPS (Basic) | -$0.53 | +65.1% |
| EPS (Diluted) | -$0.53 | +65.1% |
| Stockholders' Equity |
| $6.1M |
| -23.1% |